The North American Market to Offer High-growth Opportunities for Players Operating in the Stem Cell Therapy Market

Over the past decade, the Stem Cell Therapy Market has witnessed significant advancements in terms of product development and commercialization. Growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are the driving factors for the global stem cell therapy market. 

Browse and in-depth TOC on “Stem Cell Therapy Market”.

http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html 

 

As of 2016, North America is expected to hold the largest share of the global stem cell therapy market. This growth can be attributed to the rising public awareness related to the therapeutic potency of stem cells in disease therapy, growing number of clinical trials that aim to evaluate therapeutic potential of stem cell-based products, increasing public-private funding & research grants for developing safe and effective stem cell therapy products, and the growing patient base for target diseases. 

The allogeneic stem cell therapy segment is expected to offer high growth opportunities for players in the stem cell therapy market. This growth can primarily be attributed to factors such as wider therapeutic applications of allogeneic stem cells, easier production scale-up due to easy availability of sources of stem cells, and growing number of clinical trials of allogeneic stem cell therapies as compared to autologous stem cell therapies. Company such as MEDIPOST Co., Ltd. (South Korea), Osiris Therapeutics, Inc. (U.S.), Athersys Inc. (U.S.), JCR Pharmaceuticals Co., Ltd. (Japan), and Mesoblast Ltd. (Australia) are investing in this high-growth market for the development of safe and effective allogeneic stem cell therapy products and to gain more profits in the stem cell therapy market.

For Further Inquiry: - http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=48

In 2016, the musculoskeletal disorders segment is expected to hold the largest share of the global stem cell therapy market. This can be attributed to the high prevalence of musculoskeletal disorders and bone & joint diseases, rising market availability of stem cell-based therapeutic products across major markets, and growing patient preference for effective & early treatment strategies.